Results 141 to 150 of about 31,972 (221)

Prolactin, cortisol, and extracellular osmolality regulate <i>cftr</i>, <i>ostf1</i>, and <i>sgk1</i> in tilapia ionocytes. [PDF]

Front Endocrinol (Lausanne)
Breves JP, Hu MW, Inokuchi M, Seale LA, Seale AP.   +4 more
europepmc   +1 more source

Nasal Epithelial Organoids as Translational Platforms in Inflammatory, Infectious, and Precision Medicine Applications: A Systematic Review. [PDF]

J Clin Med
Scocca V, Lauda L, Nocini R, Dell'Aversana Orabona G.   +3 more
europepmc   +1 more source

Altered functional interactions between CFTR disease mutants ΔF508 and G551D and the protein kinase A catalytic subunit. [PDF]

J Physiol
Závoti O, Simon MA, Csanády L.
europepmc   +1 more source

The Challenges of Detecting Neutrophil CFTR. [PDF]

J Innate Immun
Flannery R, Baird R, Gogoi D, Reeves EP.
europepmc   +1 more source

When Standard Newborn Screening Isn't Enough: Diagnostic Challenges in the Age of Globalization. [PDF]

Clin Case Rep
Ortúzar Menéndez M, Mendiguren LM, Garde Garde MC, Pérez Ollo S, Campion Mezquiriz A, Moreno-Galarraga L.   +5 more
europepmc   +1 more source

Protocol for generating iPSC-derived intestinal organoids through dissection to model cystic fibrosis therapies. [PDF]

STAR Protoc
Stuffer AJ, Tabak B, Conte J, Momyer V, Chado M, Armstrong M, Wible P, Sivachenko A, Allaire N, Lu J, Mense M, Mahoney JE.   +11 more
europepmc   +1 more source

Could the Phenotypic Outcomes of Genetic Variability in Cells Operating in Mechanically Dynamic Environments be Influenced by a Disrupted "Cell-ECM" Relationship? Using Cystic Fibrosis and Marfan Syndrome as an Example. [PDF]

Bioessays
Hart DA.
europepmc   +1 more source

Targeting PI3Kγ anchoring enhances CFTR membrane localization and modulator efficacy via PKD1. [PDF]

JCI Insight
Murabito A, Mergiotti M, Capurro V, Loffreda A, Li M, Peretto P, Ren K, Raimondi A, Tacchetti C, Diviani D, Pedemonte N, Hirsch E, Ghigo A.   +12 more
europepmc   +1 more source

Patient-Derived Intestinal Organoids in the Global Cystic Fibrosis Landscape. [PDF]

Pediatr Pulmonol
Kroes S, Taylor-Cousar JL, Zampoli M, Karadag B, van der Ent CK, de Winter-de Groot KM, Beekman JM, Spelier S.   +7 more
europepmc   +1 more source

Off-label treatment with elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis: real-world evidence from the German CF Registry. [PDF]

ERJ Open Res
Stahl M, Gerts FS, Hafkemeyer S, Wosniok J, Naehrlich L, German CF Registry of the Mukoviszidose e.V. and participating sites.   +5 more
europepmc   +1 more source